Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) announced that it acquired the U.S. and Canadian rights to ZONTIVITY® (vorapaxar), pursuant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE